Last €37.25 EUR
Change Today +0.01 / 0.03%
Volume 880.2K
GRF On Other Exchanges
Symbol
Exchange
OTC US
OTC US
NASDAQ GS
OTC US
Continuous
Continuous
Frankfurt
Frankfurt
Mexico
As of 11:38 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for grifols sa (GRF)

Year over year, Grifols, S.A. has been able to grow revenues from €2.6B EUR to €2.7B EUR. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 49.27% to 48.29%. This was a driver that led to a bottom line growth from €256.7M EUR to €345.6M EUR.
View Income Statement In U.S. Dollar
Currency in
Millions of Euros
As of:Dec 31
2010
Restated
EUR
Dec 31
2011
Restated
EUR
Dec 31
2012
Restated
EUR
Dec 31
2013
Restated
EUR
4 Year
Trend
Revenues990.71,795.62,620.92,741.7
TOTAL REVENUES990.71,795.62,620.92,741.7
Cost of Goods Sold529.4968.11,291.31,323.9
GROSS PROFIT461.3827.51,329.61,417.9
Selling General & Admin Expenses, Total211.0459.3547.7558.5
R&D Expenses40.789.4124.4123.3
OTHER OPERATING EXPENSES, TOTAL251.6548.6672.1681.7
OPERATING INCOME209.7278.9657.5736.1
Interest Expense-30.1-310.4-251.8-215.4
Interest and Investment Income4.55.81.74.9
NET INTEREST EXPENSE-25.6-304.7-250.1-210.5
Income (Loss) on Equity Investments-0.9-1.1-1.4-1.2
Currency Exchange Gains (Loss)1.6-3.4-3.4-1.3
Other Non-Operating Income (Expenses)-27.1122.0-17.2-25.6
EBT, EXCLUDING UNUSUAL ITEMS157.891.6385.3497.5
Other Unusual Items, Total---11.62.6--
Legal Settlements----2.6--
Other Unusual Items---11.6----
EBT, INCLUDING UNUSUAL ITEMS157.880.0387.9497.5
Income Tax Expense42.529.8132.6155.5
Minority Interest in Earnings0.20.11.33.5
Earnings from Continuing Operations115.350.2255.4342.1
NET INCOME115.550.3256.7345.6
NET INCOME TO COMMON INCLUDING EXTRA ITEMS115.550.3256.7345.6
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS115.550.3256.7345.6
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GRF:SM €37.25 EUR +0.01

GRF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Endo International PLC $79.61 USD -2.03
Hikma Pharmaceuticals PLC 2,360 GBp +2.00
Hospira Inc $63.43 USD -1.35
STADA Arzneimittel AG €27.42 EUR +0.185
UCB SA €68.97 EUR -0.28
View Industry Companies
 

Industry Analysis

GRF

Industry Average

Valuation GRF Industry Range
Price/Earnings 27.5x
Price/Sales 3.7x
Price/Book 4.5x
Price/Cash Flow 17.0x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GRIFOLS SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.